Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the Human Immunodeficiency Virus Transmission Rate and Incidence in China

Author:

Ye Jingrong1ORCID,Lan Yun2,Wang Juan1ORCID,Feng Yi3,Lin Yi456,Zhou Ying7,Liu Jinjin8ORCID,Yuan Dan9,Lu Xinli10ORCID,Guo Weigui11ORCID,Zheng Minna12ORCID,Song Xiao13ORCID,Zhou Quanhua14ORCID,Yang Hong15ORCID,Zheng Chenli16ORCID,Guo Qi17ORCID,Yang Xiaohui18,Yang Kai19,Zhang Lincai20,Ge Zhangwen21ORCID,Liu Lifeng22,Yu Fengting23,Han Yang24,Huang Huihuang25,Hao Mingqiang1ORCID,Chen Qiang1ORCID,Ling Xuemei2,Ruan Yuhua26,Dong Yuan456ORCID,Zhou Chang9,Liu Xuangu11ORCID,Bai Jianyun12ORCID,Tong Xue13ORCID,Gao Ya15ORCID,Yang Zhengrong16,Wang Ao17,Wei Wei18,Mei Fanghua19,Qiao Ruijuan20ORCID,Luo Xinhua21,Huang Xiaojie22ORCID,Chen Jing1ORCID,Hu Fengyu2ORCID,Shen Xin456ORCID,Tan Wei16,Tu Aixia20ORCID,Zhang Xinhui27ORCID,He Shufang1ORCID,Ning Zhen456ORCID,Fan Jixiang17,Liu Cong19ORCID,Xu Conghui1ORCID,Ren Xianlong1,Sun Yanming1ORCID,Li Yang1,Liu Guowu1,Li Xiyao1,Li Jie1,Duan Junyi22,Huang Tao22,Liu Shuiqing28,Yu Guolong29ORCID,Wu Donglin17,Shao Yiming26ORCID,Pan Qichao456ORCID,Zhang Linglin9,Su Bin22,Wu Jianjun30,Jiang Tianjun25,Zhao Hongxin23,Zhang Tong22,Chen Faqing20ORCID,Cai Kun19,Hu Bing18,Wang Hui17,Zhao Jin16ORCID,Gao Baicheng15ORCID,Sun Wei13ORCID,Ning Tielin12ORCID,Li Jianjun31ORCID,Liang Shu9,Huo Yuqi8ORCID,Fu Gengfeng7,Chen Xin456,Li Feng2ORCID,Xing Hui26ORCID,Lu Hongyan1ORCID

Affiliation:

1. Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Control and Prevention (CDC) , Beijing Academy of Preventive Medicine , Beijing

2. Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University , Guangzhou

3. Division of Virology and Immunology, State Key Laboratory for Infectious Disease Prevention and Control and National Center for AIDS/STD Prevention and Control , China CDC , Beijing

4. Division of Tuberculosis and HIV/AIDS Prevention, Shanghai CDC

5. Shanghai Institutes of Preventive Medicine

6. Shanghai Center for AIDS Research , Shanghai

7. Institute of AIDS/STD Control and Prevention, Jiangsu CDC , Nanjing

8. Center for Translational Medicine, Affiliated Infectious Diseases Hospital of Zhengzhou University (Henan Infectious Diseases Hospital, The Sixth People's Hospital of Zhengzhou) , Zhengzhou

9. Center for AIDS/STD Control and Prevention, Sichuan CDC , Chengdu

10. Department of AIDS Research, Hebei Key Laboratory of Pathogen and Epidemiology of Infectious Disease, Hebei CDC , Shijiazhuang

11. Institute of HIV/AIDS Prevention and Control, Beihai CDC , Beihai

12. Department of STDs/AIDS Control and Prevention, Tianjin CDC , Tianjin

13. Institute for HIV/AIDS and STD Prevention and Control, Heilongjiang CDC , Harbin

14. Institute of Microbiology, Chongqing CDC , Chongqing

15. STD/AIDS Prevention and Control Institute, Inner Mongolia CDC (Inner Mongolia Academy of Preventive Medicine) , Hohhot

16. Department of HIV/AIDS Control and Prevention, Shenzhen CDC , Shenzhen

17. Virology Laboratory, Jilin CDC , Changchun

18. Institute for HIV/AIDS and STD Prevention and Control, Fuyang CDC , Fuyang

19. Hubei CDC , Wuhan

20. Institute for HIV/AIDS and STD Prevention and Control, Gansu CDC , Lanzhou

21. Guizhou Provincial People's Hospital, Affiliated Hospital of Guizhou University , Guiyang

22. Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University , Beijing

23. Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University , Beijing

24. Department of Infectious Disease, Peking Union Medical College Hospital , Beijing

25. Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of People’s Liberation Army General Hospital , Beijing

26. Division of Virology and Immunology, State Key Laboratory for Infectious Disease Prevention and Control and National Center for AIDS/STD Prevention and Control, China CDC , Beijing

27. Institute for Infectious Disease Prevention and Control, Guizhou CDC , Guiyang

28. Department of Infectious Diseases, Guiyang Public Health Clinical Center , Guiyang

29. Institute of Pathogenic Microbiology, Guangdong CDC , Guangzhou

30. Institute for HIV/AIDS and STD Prevention and Control, Anhui CDC , Hefei

31. Institute of HIV/AIDS Prevention and Control, Guangxi CDC , Nanning

Abstract

Abstract Background In 2016, China has implemented the World Health Organization's “treat all” policy. We aimed to assess the impact of significant improvements in the 95-95-95 targets on population-level human immunodeficiency virus (HIV) transmission dynamics and incidence. Methods We focused on 3 steps of the HIV care continuum: diagnosed, on antiretroviral therapy, and achieving viral suppression. The molecular transmission clusters were inferred using HIV-TRACE. New HIV infections were estimated using the incidence method in the European Centre for Disease Prevention and Control HIV Modelling Tool. Results Between 2004 and 2023, the national HIV epidemiology database recorded 2.99 billion person-times of HIV tests and identified 1 976 878 new diagnoses. We noted a roughly “inverted-V” curve in the clustering frequency, with the peak recorded in 2014 (67.1% [95% confidence interval, 63.7%–70.5%]), concurrent with a significant improvement in the 95-95-95 targets from 10-13-<71 in 2005 to 84-93-97 in 2022. Furthermore, we observed a parabolic curve for a new infection with the vertex occurring in 2010. Conclusions In general, it was suggested that the improvements in the 95-95-95 targets were accompanied by a reduction in both the population-level HIV transmission rate and incidence. Thus, China should allocate more effort to the first “95” target to achieve a balanced 95-95-95 target.

Funder

Beijing Municipal Health Commission

China Capital’s Funds for Health Improvement and Research

Public Health Talent Grant Global Health Governance-02-12

Capital Health Development Research

High-Level Public Health Specialized Talents Project

Beijing High-Level Public Health Doctor Cultivation Project Academic Leader-01-04

Chinese Association of STD and AIDS Prevention and Control

Liangshan Prefecture

Guangzhou Municipal Science and Technology Bureau

Science and Technology Project of Guangzhou

Science and Technology Commission of Shanghai Municipality

Natural Science Foundation of Shanghai Municipality

Bureau of Beihai City Science and Technology

Beihai Science and Technology Planning Project

Health Commission of Heilongjiang Province

Scientific Research Project of Heilongjiang Provincial Health Commission

Jilin Provincial Department of Science and Technology

Health Commission of Gansu Province

Scientific Research Project of Gansu Provincial Health Commission

National Natural Science Foundation of China

Guizhou Provincial Department of Science and Technology

Science and Technology Project of Guizhou Province qian ke he foundation–ZK 2023

Beijing Key Laboratory for HIV/AIDS Research

Shanghai Municipal Health Commission

Beijing CDC

Cultivation Fund of Beijing CDC

Department of Science and Technology of Guangdong Province

Guangdong Basic and Applied Basic Research Foundation

Key-Area Research and Development Program of Guangdong Province

Health Commission of Shenzhen Municipality

San-Ming Project of Medicine in Shenzhen

Shenzhen Key Medical Discipline Construction Fund

Department of Science and Technology of Guangxi Zhuang Autonomous Region

Guangxi Natural Science Foundation Project

Health Commission of Henan Province

Co-sponsored Construction Project of Provincial Medicine and Technique of Henan Province

Beijing Municipal Science and Technology Commission, Administrative Commission of Zhongguancun Science Park

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3